Skip to main content

Volume 2 Supplement 1


  • Poster presentation
  • Open access
  • Published:

0102. Ex vivo effects of hyperglycemia on phenotype and production of reactive oxygen species by the nadph oxidase of human immune cells in acute inflammatory response


Glucose is a major energy substrate for polymorphonuclears (PMNs) and monocytes (Monos). In acute stress, glucose was shown to be pro-inflammatory favoring the production of reactive oxygen species (ROS).


1- Demonstrate an increase in ROS production during moderate hyperglycemia by increased production of the NADPH oxidase through the pentose shunt pathway (PSP), the major source of NADPH.

2- Evaluate the phenotypic consequences on PMNs, Monos, and Lymphocytes (Lymphos).


Whole blood from healthy volunteers (CCPSL UNT -No 13/SL/015) was incubated 90 minutes either in normoglycemia (NG) or hyperglycemia (HG, 12.5 mM glucose), in the presence of deoxyglucose (DOG, 12.5 mM) blocking glycolysis, or inhibitors of the PSP (Epi Androsterone & 6 Aminonicotinamide (EPI, 6AN)). For the all conditions: evaluation of overall ROS production (luminometry1: area under the curve (AUC) & slope of activation (Slope)) in resting cell condition & after stimulation by PMA-Ionomycin. Following phenotypic parameters were evaluated: HLA-DR expression on Monos (overall population, and subtypes CD16- and CD16+) and on B cells; expression of CD11b on Monos and PMNs; CTLA4 on T4/T8 Lymphos, and CD62L (marker of cell activation) on Monos, PMNs and Lymphos. Statistics: non-parametric tests.



In resting conditions: AUC of luminometry (increased production) (n = 19) and Slope (system reactivity) were higher in HG than in NG (p< 0.05), a difference that disappeared after PMA-Ionomycin stimulation. The inhibitors (DOG, EPI + 6AN) reduced the AUC and the Slope in NG and HG (p< 0.05 and p< 0.05).

2-Cell phenotype

HG did not change the cell expression of markers for Monos (total, CD16- and CD16+), PMNs, T4 and T8 Lymphos. Only in B cell HG increased HLA-DR expression (p< 0.05). The DOG condition decreased expression of HLA-DR, CD11b and CD62L on Monos and CD62L on PMNs (p< 0.05), with no effect on Lymphos.


HG amplifies ROS production and NADPH oxidase reactivity via PSP pathway and NADPH synthesis, especially after stimulation in Monos. Absence of any impact of acute glycemic variation and of blocking glucose metabolism on T4, T8 Lymphos phenotype, strongly suggests that Lymphos do not use glucose as a major energetic substrate2. Except for B lympho, Mono and PMNs did not change their studied phenotype, with ex vivo non-significant effect on T Lymphos. Acute HG as glucose metabolic inhibitors changed ROS production but not innate immune cell phenotype.


  1. Lukaszewicz A-C, Gontier G, Faivre V, Ouanounou I, Payen D: Elevated production of radical oxygen species by polymorphonuclear neutrophils in cerebrospinal fluid infection. Ann. Intensive Care 2012, 2: 10. 10.1186/2110-5820-2-10

    Article  PubMed Central  PubMed  Google Scholar 

  2. Pearce EL, Pearce EJ: Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38: 633–643. 10.1016/j.immuni.2013.04.005

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soyer, B., Faivre, V., Damoisel, C. et al. 0102. Ex vivo effects of hyperglycemia on phenotype and production of reactive oxygen species by the nadph oxidase of human immune cells in acute inflammatory response. ICMx 2 (Suppl 1), P13 (2014).

Download citation

  • Published:

  • DOI: